abstract |
This invention provides compounds of formula IA: n n n n n n n n n n and also provides compounds of formula IIA, IIIA, IVA, or VA: n n n n n n n n n n n n wherein HY, R 1 , R 2 , R 3 , R 14 , G 1 , G 2 , G 3 , and G 4 , are as described in the specification. The compounds are inhibitors of VPS34 and/or PI3K and are thus useful for treating proliferative, inflammatory, or cardiovascular disorders. |